Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS3: Hypertonic Saline in Aneurysmal SAH
NCT02432157Phase 2Unknown
- Sponsor
- Thomas Jefferson University
- Start
- Jan 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of hypertonic saline in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Thomas Jefferson University. Status: unknown.
02
Drugs
hypertonic saline
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT02432157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432157.